// App-Quantinova.ai

2097 : Higher CSA Levels After Umbilical Cord Blood Transplant For Acute Leukemia Result In Improved Survival

Researchers

Presenter

  • Heather E Stefanski

Principal Investigators

  • Michael J Burke

  • Qing Cao

  • Angela R. Smith

  • Margaret L. MacMillan

  • Erica D. Warlick

  • Daniel J. Weisdorf

  • John E. Wagner

  • Michael R. Verneris

Medical Centers

  • Medical College of Wisconsin, Division of Pediatric Hematology/Oncology/BMT, Milwaukee, WI

  • Pediatric Blood and Marrow Tranplant, University of Minnesota Amplatz Children's Hospital, Minneapolis, MN

  • Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN

  • Department of Pediatric Blood and Marrow Transplant, University of Minnesota, Minneapolis, MN

  • Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN

  • Biostatistic Support, Masonic Cancer Center, Minneapolis, MN

  • Division of Hematology Oncology and Transplantation, University of Minnesota, Minneapolis, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Graft-versus-host disease

  • Acute Leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Cyclosporine A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved